PGP and central nervous system disorder: Since this initial work, PET has also been used to evaluate whether alterations of P-gp function at the BBB are implicated in the pharmacoresistance of some HIV and epilepsy patients to therapeutics or if P-gp function is either compromised or enhanced in several other central nervous system disorders[62].